Silobreaker.com    Log In
   My Page    Help   
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 5:46 AM

IMS Health Inc

IMS Health Inc - Click to view 360-page
IMS Health Inc
Type: Company
Name: IMS Health Inc
First Reported 11/19/2009 - Updated 11/19/2009 - 2 Documents (in Medicine)
Pete Stark - Click to view image in its original context
Pete Stark
Congress investigates rising drug prices
NEW YORK (Nov. 19) An article in The New York Times about rising drug prices has sparked an investigation by members of Congress, the newspaper reported Thursday.Based on calculations by Wall Street analysts, IMS Health and AARP, the Times reported Sunday ... [Drug Store News - 11/19/2009]
First Reported 11/19/2009 - Updated 11/19/2009 - 1 Documents (in Politics)
Pharma will benefit from US reforms for many decades “Potentailly over 39 million new customers"
Moreover, while pharmaceutical industry leaders at the Reuters Health Summit are optimistic about the effects on their US businesses of extending health insurance to up to 39 million people who are currently uninsured.FOR IMMEDIATE RELEASEPRLog (Press ... [Prlog - 11/19/2009]
First Reported 11/16/2009 - Updated 11/16/2009 - 1 Documents (in Internet & IT)
Big Pharma Deal with White House on Course to Net Industry Billions
A private industry report found that the deal struck between the pharmaceutical lobby, the White House and Senate Democrats has drastically improved Big Pharma's expected profits.IMS Health, a company that supplies the pharmaceutical companies with sales ... [Mercola - 11/16/2009]
First Reported 11/16/2009 - Updated 11/16/2009 - 1 Documents (in Health)
Food and Drug Administration - Click to view 360-page
Food and Drug Administration
FDA approves Par's chronic pain drug
WOODCLIFF LAKE, N.J. (Nov. 16) The Food and Drug Administration has approved a generic version of a chronic pain drug.Par Pharmaceuticals announced Monday the approval of tramadol extended-release tablets in the 100-mg and 200-mg strengths. The drug is ... [Drug Store News - 11/16/2009]
First Reported 11/17/2009 - Updated 11/17/2009 - 1 Documents (in Politics)
Novo Nordisk - Click to view image in its original context
Novo Nordisk
Pharma “will not benefit from US reforms before 2015”
As debate on the US Senate health reform legislation commences, likely this week, experts forecast that drugmakers will not feel any financial benefits of the reforms before 2015.Technically, Senators could begin their debate as early as Tuesday (November ... [Pharma Times - 11/17/2009]
First Reported 11/17/2009 - Updated 11/17/2009 - 1 Documents
Equity Residential - Click to view 360-page
Equity Residential
RX, ECL, PNK, CBB, PWE and EQR Receives Analytical Coverage from ...
Companies: Cincinnati Bell, Inc. (CBB), Ecolab Inc. (ECL), Equity Residential (EQR), IMS Health, Inc. (RX), Penn West Energy Trust (PWE), Pinnacle Entertainment, Inc. (PNK)Wallstsense.com is an online community with a dedicated team of analysts who are ... [Zibb - 11/17/2009]
First Reported 11/17/2009 - Updated 11/17/2009 - 1 Documents (in Politics)
TPG Capital LLP - Click to view image in its original context
TPG Capital LLP
Let Insurers Own Patients Like Baseball Players And Costs Will Plummet
Maybe we should allow people to sell the lifetime right to health insurance coverage as if it were an asset that health care insurers could trade, according to The Health Care Blog. This would give insurance companies a long-term incentive to keep you ... [Clusterstock - 11/17/2009]
First Reported 11/18/2009 - Updated 11/18/2009 - 1 Documents
IMS Health being sold for US$5.2 billion
IMS Health is being sold to investment funds TPG Capital and CPP Investment Board in a deal valued at US$5.2 billion.Chief executive David Carlucci says the sale is expected to be finalised by the first quarter of 2010 and would allow the company to continue ... [Pharmacy Today - 11/18/2009]
First Reported 11/18/2009 - Updated 11/18/2009 - 1 Documents
Covington Advises Foros Securities in IMS Health $5.2B LBO Deal
– IMS Health today announced that it has entered into a definitive agreement to be acquired by investment funds managed by TPG Capital (TPG) and the CPP Investment Board (CPPIB) in a transaction with a total value of $5.2 billion, including the assumption ... [Jaffe Legal News Service - 11/18/2009]
First Reported 11/05/2009 - Updated 11/06/2009 - 33 Documents (in Corporate Deals)
TPG Capital, CPPIB team up for $5.2bn pharma deal
TPG Capital, alongside the Canada Pension Plan Investment Board, will acquire IMS Health, one of the world’s leading providers of market intelligence to the pharmaceutical and healthcare industries, in a deal valued at $5.2bn.This is understood to be ... [AltAssets.net - 11/06/2009]
First Reported 11/06/2009 - Updated 11/07/2009 - 6 Documents
IMS Health Is Being Bought By TPG Capital And CPP Investment Board For $4 Billion (RX)
11/5/2009 - IMS Health Inc. (NYSE:RX) said Thursday that it is being bought by investment funds TPG Capital and CPP Investment Board for $4 billion. IMS shareholders are getting $22 per share under the terms of the deal, which is a 31% premium to the ... [Individual.com - 11/07/2009]
First Reported 11/11/2009 - Updated 11/12/2009 - 7 Documents (in Health)
IMS Health to launch comprehensive analytical tool for oncology market
IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the upcoming launch of IMS Oncology QuantifierTM, a comprehensive, clinically rich analytical tool that enables ... [News-Medical.Net - 11/12/2009]

Quotes

...Smart people have been asking, "Why isn't anybody really paid to help me stay healthy, rather than to just treat me when I am sick?" To answer that question, we have to identify what economic value is created by your staying healthy, and who gets that value...
Let Insurers Own Patients Like Baseball Players And Costs Will Plummet [Clusterstock - 11/17/2009]
...to be commercialised in the country by the first quarter of next financial year, informs Teruo Yasufuku, managing director, Astellas Pharma India. "The awareness on cadever organ donation is very little in India, like many other countries, and we will be working with the NGOs to spread awareness among public probably from the time of our product launch. At present the market is dominated by generic products and we expect that our product would become the market leader in the transplantation segment in coming years" said Teruo. However, he refused to divulge more on the marketing strategy commenting that the model is yet to be finalised...
Astellas Pharma set to launch Prograf in India, works on marketing strategy [PharmaBiz - 11/13/2009]
..."Obesity is a complex disease likely requiring multiple treatment options," said Amylin spokeswoman Anne Erickson. "We believe our peptide and multi-hormonal approach to developing obesity therapies has the promise to introduce effective medicines with strong safety profiles." Local competitors Arena Pharmaceuticals Inc. and Orexigen Therapeutics Inc...
Amylin Obesity Drug Grabbing the Attention of Analysts, Investors [San Diego Business Journal - 11/09/2009]
...aerospace investment firm in Century City, said the sale came at a time when many private equity firms have been under pressure to get a deal done. "Many firms haven't made a deal in the last 18 months, and there's anxiety out there to get something completed" he said. 'This is a natural sale to extend on, even with such a large price attached...
Northrop Grumman to sell government advisory business for $1.65 billion [Los Angeles Times - 11/09/2009]

More Content

All (564) | News (512) | Reports (1) | Blogs (48) | Audio/Video (0) | Fact Sheets (3)
sort by: Date | Relevance
Pharma will benefit from US reforms for many de... [Prlog - 11/19/2009]
Masters of the Universe are back - The Buzz [CNN Money - 11/19/2009]
Notable 52-Week NYSE New Highs and Lows 11/19: ... [Street Insider - 11/19/2009]
Congress investigates rising drug prices [Drug Store News - 11/19/2009]
The Masters of the Universe are back [CNN Money - 11/19/2009]
Rising Prices of Drugs Lead to Call for Inquiry [New York Times - 11/19/2009]
Covington Advises Foros Securities in IMS Healt... [Jaffe Legal News Service - 11/18/2009]
IMS Health being sold for US$5.2 billion [Pharmacy Today - 11/18/2009]
FDA issues heartburn drug warning [Chicago Tribune - 11/18/2009]
Par Pharma gets US FDA nod to market tramadol [PharmaBiz - 11/18/2009]
FDA warns against mixing Nexium or Prilosec wit... [Los Angeles Times - 11/18/2009]
RX, ECL, PNK, CBB, PWE and EQR Receives Analyti... [Zibb - 11/17/2009]
Lazard Names Kenneth M. Jacobs Chairman and Chi... [Business Wire - 11/17/2009]
Lazard Names Kenneth M. Jacobs Chairman and Chi... [RBC Dain Rauscher - 11/17/2009]
RX, ECL, PNK, CBB, PWE and EQR Receives Analyti... [Individual.com - 11/17/2009]
Par Pharmaceutical granted final approval to ma... [M2 - 11/17/2009]
Pharma “will not benefit from US reforms before... [Pharma Times - 11/17/2009]
FDA approves Par Pharmaceutical's new painkille... [News-Medical.Net - 11/17/2009]
Par Pharmaceutical Receives Final Approval to M... [PharmaceuticalProcessing - 11/16/2009]
Par Pharmaceutical Receives Final Approval to M... [Pharmacy Choice - 11/16/2009]
Par Pharmaceutical Receives Final Approval to M... [PR Newswire - 11/16/2009]
FDA approves Par's chronic pain drug [Drug Store News - 11/16/2009]
Big Pharma Deal with White House on Course to N... [Mercola - 11/16/2009]
Par Pharmaceutical Receives Final Approval to M... [Yahoo! Canada - 11/16/2009]
Par Pharma Receives Final Approval To Market Ge... [RTTNews.com - 11/16/2009]
Par Pharma (PRX) Receives Final U.S. FDA Approv... [Street Insider - 11/16/2009]
NYT: Drug prices up ahead of reform [MSNBC - 11/16/2009]
NYT: Drug firms raise prices ahead of reform [MSNBC - 11/16/2009]
Study raises questions on cholesterol medications [Tampa Tribune - 11/15/2009]
Glenmark gets FDA nod to sell anti-fungal cream... [Financial Chronicle - 11/14/2009]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
Joe Kendall, Melissa Francis, Tom Ryan, [more]
  •  
TPG Capital LLP, New York Stock Exchange, Mylan Incorporated, [more]
  •  
Food and Drug Administration, Ontario Teachers Pension Plan Board, Federal Reserve System, [more]
  •  
Private Equity, Health Care, Pension Plan, [more]
  •  
Toronto, San Francisco (United States), Plymouth Meeting (United States), [more]
  •  
Canada, United States, China, [more]
  •  
Mergers & Acquisitions, Internet & IT, Medicine, [more]
  •  
Pharma & Biotech, Health, IT, [more]
Street Insider, Individual.com, RTTNews.com, [more]
Content Volume
Network
Trends

Blogs

sort by: Date | Relevance
Let Insurers Own Patients Like Baseball Players... [Clusterstock - 11/17/2009]
Maybe we should allow people to sell the lifetime right to health insurance coverage as if it were an asset that health care insurers could trade, according to The ...
Corporatecare for PhRMA [Daily Kos - 11/16/2009]
Last week Jon Cohn and Sam Stein reported on a just how much of a sweetheart deal PhRMA actually got by negotiating with Baucus and the White House on reform efforts. ...
Do the White House and Senate Still Stand by Th... [Firedoglake - 11/16/2009]
(photo by Scott Ableman) There has been enough information in the last two weeks on the outrageous practices of the major drug manufacturers to warrant extensive ...
IMS Health Merger Likely to Close [Long Investment Ideas from Seeking Alpha - 11/13/2009]
On 05-Nov-09 IMS Health Inc (RX), the US healthcare information company, announced it had signed an agreement to be acquired by TPG Capital and the Canada Pension ...
IMS Health Merger Likely to Close [Healthcare Sector and Stocks Analysis from Seek ... - 11/13/2009]
On 05-Nov-09 IMS Health Inc (RX), the US healthcare information company, announced it had signed an agreement to be acquired by TPG Capital and the Canada Pension ...
1 2 3 4 5 6 7 8 9 10

  •  
  •  
  •